Memorial Sloan Kettering Cancer Center is a cancer treatment and research institution in the borough of Manhattan in New York City, founded in 1884 as the New York Cancer Hospital.

There are 498 (2018) beds in Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy.

During the past decade, Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy" are "Acute Myeloid Leukemia" (1 trials), "Advanced Malignancies" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials), "Leiomyosarcoma" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy" in a lesser frequency.

Most popular intervention types in "Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Anti-CD20 Targeting agent" (1 trials), "Avelumab" (1 trials), "Avelumab (MSB0010718C)" (1 trials), "Axitinib" (1 trials) and "Axitinib (AG-013736)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".